サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1788505

ナノテクノロジーによるドラッグデリバリーの世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025～2035年)

Nanotechnology Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 192 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
ナノテクノロジーによるドラッグデリバリーの世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025～2035年)
出版日: 2025年06月18日
発行: Transparency Market Research
ページ情報: 英文 192 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノテクノロジーによるドラッグデリバリー - 分析範囲

TMRの調査レポート「ナノテクノロジーによるドラッグデリバリーの世界」は、2025～2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去および現在の成長動向と機会を調査しています。2025年を基準年、2035年を予測年として、2025～2035年までの世界のナノテクノロジーによるドラッグデリバリーの収益と予測を提供します。また、2025～2035年までの世界のナノテクノロジーによるドラッグデリバリーの複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、ナノテクノロジーによるドラッグデリバリー市場を推察しました。

市場スナップショット
市場規模（2024年） 978億米ドル
市場規模（2035年） 3,159億米ドル
CAGR 11.3%

当レポートでは、世界のナノテクノロジーによるドラッグデリバリー市場の競合情勢について調査しています。世界のナノテクノロジーによるドラッグデリバリーで事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のナノテクノロジーによるドラッグデリバリーのプレイヤーの属性です。

世界のナノテクノロジーによるドラッグデリバリーレポートが回答する主な質問

  • 予測期間中の全地域におけるアフェレシスによる売上/収益は？
  • 世界のナノテクノロジーによるドラッグデリバリー市場におけるビジネスチャンスは？
  • 市場の主な促進要因、市場抑制要因、機会、脅威は何か？
  • 予測期間中に最も速いCAGRで拡大する地域市場はどこか？
  • 2035年に世界で最も高い収益を上げると予測されるセグメントは？
  • 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
  • 世界市場で事業を展開する各企業の市場ポジションは？

ナノテクノロジーによるドラッグデリバリー - 調査目的と調査手法

ナノテクノロジーによるドラッグデリバリーの世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳細に説明しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけます。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできます。

本レポートでは、世界のナノテクノロジーによるドラッグデリバリーを製品タイプ、投与経路、地域等の観点から分析しています。各基準における主要セグメントを詳細に調査し、2035年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場利害関係者は、世界のナノテクノロジーによるドラッグデリバリー市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のナノテクノロジーによるドラッグデリバリー市場分析と予測（2020～2035年）

第5章 主要洞察

  • 主要な業界イベント
  • 主要国・地域別の疫学
  • サプライチェーン分析
  • 技術的進歩
  • 主要国・地域別の規制シナリオ
  • 市場参入戦略
  • 主要製品/ブランド分析
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 競合が提供する製品のベンチマーク

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：製品タイプ別（2020～2035年）
    • ナノ粒子
    • リポソーム
    • ミセル
    • ナノ懸濁液
    • デンドリマー
    • ナノチューブ
    • その他
  • 市場の魅力：製品タイプ別

第7章 世界市場の分析と予測：投与経路別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：投与経路別（2020～2035年）
    • 経口
    • 非経口
    • 局所
    • その他
  • 市場の魅力：投与経路別

第8章 世界市場の分析と予測：用途別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：用途別（2020～2035年）
    • 腫瘍
    • 神経疾患
    • 心血管疾患
    • 感染症
    • 呼吸器疾患
    • 自己免疫疾患
    • その他（眼科など）
  • 市場の魅力：用途別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：エンドユーザー別（2020～2035年）
    • 病院・診療所
    • バイオ医薬品企業
    • その他
  • 市場の魅力：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測（金額ベース）：：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米の市場分析と予測

  • 米国
  • カナダ

第12章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • スイス
  • オランダ
  • その他欧州地域

第13章 アジア太平洋地域の市場分析と予測

  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第14章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ地域

第15章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析企業別（2024年）
  • 企業プロファイル
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis AG
    • Roche Holding AG
    • AbbVie Inc.
    • Sanofi S.A.
    • Amgen Inc.
    • Celgene Corporation
    • Gilead Sciences, Inc.
図表

List of Tables

  • Table 01: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 03: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 04: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 05: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 06: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 07: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Product Type, 2020 to 2035
  • Table 08: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 09: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 10: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 11: Europe Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 12: Europe Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Product Type, 2020 to 2035
  • Table 13: Europe Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 14: Europe Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 15: Europe Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 16: Asia Pacific Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 17: Asia Pacific Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Product Type, 2020 to 2035
  • Table 18: Asia Pacific Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 19: Asia Pacific Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 20: Asia Pacific Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 21: Latin America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 22: Latin America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Product Type, 2020 to 2035
  • Table 23: Latin America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 24: Latin America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 25: Latin America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 26: Middle East & Africa Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 27: Middle East & Africa Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, by Product Type, 2020 to 2035
  • Table 28: Middle East & Africa Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 29: Middle East & Africa Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Middle East & Africa Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 02: Global Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 03: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 04: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Nanoparticles, 2020 to 2035
  • Figure 05: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Liposomes, 2020 to 2035
  • Figure 06: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Micelles, 2020 to 2035
  • Figure 07: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Nanosuspensions, 2020 to 2035
  • Figure 08: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Dendrimers, 2020 to 2035
  • Figure 09: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Nanotubes, 2020 to 2035
  • Figure 10: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 11: Global Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 12: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 13: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Oral, 2020 to 2035
  • Figure 14: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Parenteral, 2020 to 2035
  • Figure 15: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Topical, 2020 to 2035
  • Figure 16: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 17: Global Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 18: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 19: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Oncology, 2020 to 2035
  • Figure 20: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Neurology, 2020 to 2035
  • Figure 21: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Cardiovascular Diseases, 2020 to 2035
  • Figure 22: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Infectious Diseases, 2020 to 2035
  • Figure 23: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Respiratory Diseases, 2020 to 2035
  • Figure 24: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Autoimmune Diseases, 2020 to 2035
  • Figure 25: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 26: Global Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 27: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 28: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Hospitals and Clinics, 2020 to 2035
  • Figure 29: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Biopharmaceutical Companies, 2020 to 2035
  • Figure 30: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 31: Global Nanotechnology Drug Delivery Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 32: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 33: North America Nanotechnology Drug Delivery Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 34: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 35: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 36: North America Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 37: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 38: North America Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 39: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 40: North America Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 41: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 42: North America Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 43: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 44: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 45: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 46: Europe Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 47: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 48: Europe Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 49: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 50: Europe Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 51: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 52: Europe Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 53: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 54: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 55: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 56: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 57: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 58: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 59: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 60: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 61: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 62: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 63: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 64: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 65: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 66: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 67: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 68: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 69: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 70: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 71: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 72: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 73: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 74: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 76: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 77: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 78: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 79: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 80: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 81: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 82: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 83: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, By End-user, 2025 to 2035
目次
Product Code: TMRGL86739

Nanotechnology Drug Delivery - Scope of Report

TMR's report on the global Nanotechnology Drug Delivery studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Nanotechnology Drug Delivery for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Nanotechnology Drug Delivery from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 97.8 Bn
Market Value in 2035US$ 315.9 Bn
CAGR11.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Nanotechnology Drug Delivery have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Nanotechnology Drug Delivery profiled in this report.

Key Questions Answered in Global Nanotechnology Drug Delivery Report:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nanotechnology Drug Delivery - Research Objectives and Research Approach

The comprehensive report on the global Nanotechnology Drug Delivery begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Nanotechnology Drug Delivery in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Nanotechnology Drug Delivery Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Epidemiology by Key Countries/Regions
  • 5.3. Supply Chain Analysis
  • 5.4. Technological advancements
  • 5.5. Regulatory Scenario by Key Countries/Regions
  • 5.6. Go to Market Strategy
  • 5.7. Key Product/Brand Analysis
  • 5.8. Porter's Five Forces Analysis
  • 5.9. PESTLE Analysis
  • 5.10. Benchmarking of Products offered by Competitors

6. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020 to 2035
    • 6.3.1. Nanoparticles
    • 6.3.2. Liposomes
    • 6.3.3. Micelles
    • 6.3.4. Nanosuspensions
    • 6.3.5. Dendrimers
    • 6.3.6. Nanotubes
    • 6.3.7. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Topical
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Route of Administration

8. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2020 to 2035
    • 8.3.1. Oncology
    • 8.3.2. Neurology
    • 8.3.3. Cardiovascular Diseases
    • 8.3.4. Infectious Diseases
    • 8.3.5. Respiratory Diseases
    • 8.3.6. Autoimmune Diseases
    • 8.3.7. Others (Ophthalmology, etc.)
  • 8.4. Market Attractiveness By Application

9. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020 to 2035
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Biopharmaceutical Companies
    • 9.3.3. Others
  • 9.4. Market Attractiveness By End-user

10. Global Nanotechnology Drug Delivery Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Nanotechnology Drug Delivery Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020 to 2035
    • 11.2.1. Nanoparticles
    • 11.2.2. Liposomes
    • 11.2.3. Micelles
    • 11.2.4. Nanosuspensions
    • 11.2.5. Dendrimers
    • 11.2.6. Nanotubes
    • 11.2.7. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 11.3.1. Oral
    • 11.3.2. Parenteral
    • 11.3.3. Topical
    • 11.3.4. Others
  • 11.4. Market Value Forecast By Application, 2020 to 2035
    • 11.4.1. Oncology
    • 11.4.2. Neurology
    • 11.4.3. Cardiovascular Diseases
    • 11.4.4. Infectious Diseases
    • 11.4.5. Respiratory Diseases
    • 11.4.6. Autoimmune Diseases
    • 11.4.7. Others (Ophthalmology, etc.)
  • 11.5. Market Value Forecast By End-user, 2020 to 2035
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Biopharmaceutical Companies
    • 11.5.3. Others
  • 11.6. Market Value Forecast By Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Route of Administration
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Nanotechnology Drug Delivery Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020 to 2035
    • 12.2.1. Nanoparticles
    • 12.2.2. Liposomes
    • 12.2.3. Micelles
    • 12.2.4. Nanosuspensions
    • 12.2.5. Dendrimers
    • 12.2.6. Nanotubes
    • 12.2.7. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 12.3.1. Oral
    • 12.3.2. Parenteral
    • 12.3.3. Topical
    • 12.3.4. Others
  • 12.4. Market Value Forecast By Application, 2020 to 2035
    • 12.4.1. Oncology
    • 12.4.2. Neurology
    • 12.4.3. Cardiovascular Diseases
    • 12.4.4. Infectious Diseases
    • 12.4.5. Respiratory Diseases
    • 12.4.6. Autoimmune Diseases
    • 12.4.7. Others (Ophthalmology, etc.)
  • 12.5. Market Value Forecast By End-user, 2020 to 2035
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Biopharmaceutical Companies
    • 12.5.3. Others
  • 12.6. Market Value Forecast By Country/Sub Region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Switzerland
    • 12.6.7. The Netherlands
    • 12.6.8. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Route of Administration
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub Region

13. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020 to 2035
    • 13.2.1. Nanoparticles
    • 13.2.2. Liposomes
    • 13.2.3. Micelles
    • 13.2.4. Nanosuspensions
    • 13.2.5. Dendrimers
    • 13.2.6. Nanotubes
    • 13.2.7. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 13.3.1. Oral
    • 13.3.2. Parenteral
    • 13.3.3. Topical
    • 13.3.4. Others
  • 13.4. Market Value Forecast By Application, 2020 to 2035
    • 13.4.1. Oncology
    • 13.4.2. Neurology
    • 13.4.3. Cardiovascular Diseases
    • 13.4.4. Infectious Diseases
    • 13.4.5. Respiratory Diseases
    • 13.4.6. Autoimmune Diseases
    • 13.4.7. Others (Ophthalmology, etc.)
  • 13.5. Market Value Forecast By End-user, 2020 to 2035
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Biopharmaceutical Companies
    • 13.5.3. Others
  • 13.6. Market Value Forecast By Country/Sub Region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. South Korea
    • 13.6.5. Australia & New Zealand
    • 13.6.6. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Route of Administration
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub Region

14. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020 to 2035
    • 14.2.1. Nanoparticles
    • 14.2.2. Liposomes
    • 14.2.3. Micelles
    • 14.2.4. Nanosuspensions
    • 14.2.5. Dendrimers
    • 14.2.6. Nanotubes
    • 14.2.7. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 14.3.1. Oral
    • 14.3.2. Parenteral
    • 14.3.3. Topical
    • 14.3.4. Others
  • 14.4. Market Value Forecast By Application, 2020 to 2035
    • 14.4.1. Oncology
    • 14.4.2. Neurology
    • 14.4.3. Cardiovascular Diseases
    • 14.4.4. Infectious Diseases
    • 14.4.5. Respiratory Diseases
    • 14.4.6. Autoimmune Diseases
    • 14.4.7. Others (Ophthalmology, etc.)
  • 14.5. Market Value Forecast By End-user, 2020 to 2035
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Biopharmaceutical Companies
    • 14.5.3. Others
  • 14.6. Market Value Forecast By Country/Sub Region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Argentina
    • 14.6.4. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Route of Administration
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub Region

15. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2020 to 2035
    • 15.2.1. Nanoparticles
    • 15.2.2. Liposomes
    • 15.2.3. Micelles
    • 15.2.4. Nanosuspensions
    • 15.2.5. Dendrimers
    • 15.2.6. Nanotubes
    • 15.2.7. Others
  • 15.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 15.3.1. Oral
    • 15.3.2. Parenteral
    • 15.3.3. Topical
    • 15.3.4. Others
  • 15.4. Market Value Forecast By Application, 2020 to 2035
    • 15.4.1. Oncology
    • 15.4.2. Neurology
    • 15.4.3. Cardiovascular Diseases
    • 15.4.4. Infectious Diseases
    • 15.4.5. Respiratory Diseases
    • 15.4.6. Autoimmune Diseases
    • 15.4.7. Others (Ophthalmology, etc.)
  • 15.5. Market Value Forecast By End-user, 2020 to 2035
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Biopharmaceutical Companies
    • 15.5.3. Others
  • 15.6. Market Value Forecast By Country/Sub Region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Route of Administration
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub Region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. Merck & Co., Inc.
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Pfizer Inc.
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Johnson & Johnson
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Novartis AG
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Roche Holding AG
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. AbbVie Inc.
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Sanofi S.A.
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Amgen Inc.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Celgene Corporation
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Gilead Sciences, Inc.
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments